Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q3

Stryker, Johnson & Johnson and Zimmer Biomet posted their third quarter financial results, along with data on how their orthopedic segments performed.

Advertisement

Here is how their third-quarter finances compare:

 

Stryker 

Total sales: $4.5 billion (+7.7 percent) 

Orthopedics and spine: $1.9 billion (+4.4 percent) 

Hips: $347 million (+5.6 percent)

Knees: $481 million (+9.6 percent)

Johnson & Johnson

Total sales: $23.8 billion (+1.9 percent)

Spine, sports and other: $708 million (+0.3 percent) 

Orthopedic: $2.0 billion (+0.1 percent) 

Hips: $352 million (-0.9 percent)

Knees: $317 million (+0.4 percent)

Zimmer Biomet

Total sales: $1.7 billion (-0.9 percent)

Hips: $468 million (+3.1 percent) 

Knees: $657 million (+1.4 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $409.4 million (-6.4 percent)

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.